Adding Chemo Not Better for Recurrent Endometrial Cancer

(MedPage Today) -- NEW YORK -- Women with recurrent endometrial cancer do not benefit from receiving weekly cisplatin chemotherapy on top of standard radiation, according to findings from a randomized trial. Among patients getting cisplatin...

https://www.medpagetoday.com/meetingcoverage/igcs/101032

Source: MedPage Today Hematology/Oncology - October 3, 2022 Category: Hematology Source Type: news